STTR Phase I: Implementation of a Biometric Data Software Platform to Augment Mental Health Treatment

STTR 第一阶段：实施生物识别数据软件平台以增强心理健康治疗

• 批准号: 1820209
• 负责人: Adam Pardes
• 金额: $ 22.45万
• 依托单位: NeuroFlow, Inc.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-15 至 2019-12-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1820209&HistoricalAwards=false
• 关键词: STTR; Phase; Implementation; Biometric; Data

The broader impact/commercial potential of this Small Business Technology Transfer (STTR)project is to improve outcomes and decrease costs in the mental health space by engagingpatients starting with their first therapy session through objective progress reporting andpost-session motivation. Patients and clinicians alike will be able to track and assess treatmentprogress through self-reported and physiological measures. This innovation builds upon thestrong academic, government, and industry partnerships that will advance research andinnovation in the field of biotechnology. By demonstrating improved outcomes and decreasedcosts associated with the utilization of technology, this will pave the way for insurancereimbursement (using existing CPT codes) to accelerate market adoption. Additionally, aseducation of patients and the public improves regarding mental health and PTSD in particular,the negative stigma surrounding these conditions will decrease and more people in need willseek help rather than resorting to unhealthy behavior or even suicide.This STTR Phase I project proposes to represent an innovative approach that provides easy tointerpret results tailored to mental health providers, patients, and other non-technical users.Current mental health treatment and assessment has lacked qualitative, scientifically-basedmeasurement. The need for a scientific measurement is evident, as about 8 percent of alladults - 1 of 13 people in this country will develop PTSD during their lifetime. Currently, 60%of adults diagnosed with a mental illness don't receive mental health treatment; using provenscience and physiologic measurements as the foundation for improving treatment andmonitoring progress for PTSD can help to alleviate some of the stigma surrounding mentalillnesses. This project aims to demonstrate how implementing a web-based platform canimprove PTSD treatment by providing physiologically relevant feedback to the patient and byproviding a tool for the clinician to tailor the therapy to the individual patient. Patients will havetheir subjective measures and physiological data visualized throughout treatment on a softwareplatform, with progress being tracked through validated assessment scales. Patients will becompared to others in treatment as usual. Results should yield improved quality of life anddecrease long term healthcare costs for those that use the platform.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这个小型企业技术转移（STTR）项目的更广泛的影响/商业潜力是，通过客观的进度报告和职位课程动机，从他们的第一次治疗课程开始，通过参与他们的第一次治疗课程来改善和降低心理健康领域的成本。患者和临床医生都将能够通过自我报告和生理措施跟踪和评估治疗过程。这项创新基于Thestrong的学术，政府和行业伙伴关系，这些伙伴关系将推进生物技术领域的研究和信息。通过证明与技术利用相关的改进结果和降低的结果，这将为保险费（使用现有的CPT代码）加速采用市场采用的保险。此外，尤其是在心理健康和PTSD方面的ASDUCATION和公众的改善，围绕这些条件的负面污名将减少，需要更多需要WillSeek帮助的人，而不是诉诸于不健康的行为甚至自杀。一种创新的方法，可为精神卫生提供者，患者和其他非技术用户量身定制易于解释结果。流动的心理健康治疗和评估缺乏基于科学的定性，基于科学的测量。对科学测量的需求显而易见，因为大约8％的Alladults-该国13人中有1人一生将发展为PTSD。目前，有60％的被诊断出患有精神疾病的成年人没有接受心理健康治疗；使用普遍的科学和生理测量作为改善PTSD治疗和监控进度的基础，可以帮助减轻一些围绕精神的污名。该项目旨在证明如何通过向患者提供与生理相关的反馈来实施基于Web的平台CANIMPROVE PTSD治疗，并通过为临床医生提供一种工具，以便临床医生为患者定制治疗。患者将在整个治疗中可视化的主观措施和生理数据，以软培养的治疗，通过经过验证的评估量表来跟踪进展。患者将像往常一样在治疗中成为其他人。结果应为使用该平台的人提供改善的生活质量和偿还的长期医疗保健费用。该奖项反映了NSF的法定任务，并被认为是值得通过基金会的知识分子优点和更广泛的影响来通过评估来支持的。